Clinical Trials Browser

Completed × Mifepristone × Clear all

NCT00133705 2023-09-25

Trial of Mifepristone for Fibroids

Phase 3 Completed

70 enrolled 6 charts

Leiomyoma

NCT02012296 2022-07-13

Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer

Phase 1/2 Completed

88 enrolled 14 charts

Prostatic Neoplasms

NCT02651844 2022-05-06

MIPRA

Phase NA Completed

Breast Neoplasms

NCT01898312 2022-01-19

BRCA1/2 and Effect of Mifepristone on the Breast

Phase 2 Completed

Women With Mutations in the Breast Cancer Susceptibility Genes BRCA1,2

NCT03015701 2019-12-23

S9005 Mifepristone in Meningioma

Phase 3 Completed

Meningioma

NCT01493310 2018-09-12

Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer

Phase 1 Completed

Breast Neoplasms, Breast Neoplasms, Male

NCT02046421 2018-09-11

Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Phase 1 Completed

BreastGynecologic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Fallopian Tube Neoplasms, Breast Neoplasms, Male

NCT00459290 2018-07-18

Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Phase 2 Completed

24 enrolled 12 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02014337 2018-01-17

Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors

Phase 1 Completed

BreastGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma

NCT00579475 2015-05-25

The Effect of Mifepristone on Uterine Fibroids and Breast Tissue

Phase 1 Completed

Leiomyoma

NCT00886873 2014-10-17

Mifemyo_2

Phase 2/3 Completed

Leiomyoma

NCT00936741 2014-04-02

An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome

Phase 3 Completed

30 enrolled 8 charts

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Choristoma, Cushing Syndrome, Hirsutism, Pituitary Diseases, Pituitary ACTH Hypersecretion

NCT01371565 2014-03-18

Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome

Phase 3 Completed

4 enrolled 7 charts

ACTH Syndrome, Ectopic, Cushing Syndrome, Pituitary Diseases, Pituitary ACTH Hypersecretion

NCT00569582 2013-08-22

SEISMIC

Phase 3 Completed

50 enrolled 8 charts

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Choristoma, Cushing Syndrome, Hirsutism, Pituitary Diseases, Pituitary ACTH Hypersecretion

NCT00881140 2012-12-19

Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids

Phase 2 Completed

Leiomyoma, Uterine Hemorrhage

NCT00505739 2012-07-30

Mifepristone for Patients With Endometrial Cancer and LGESS

Phase 2 Completed

Endometrial Neoplasms, Endometrial Stromal Tumors

NCT00140478 2009-12-09

Mifepristone (RU-486) in Androgen Independent Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00712595 2009-04-23

Mifemyo

Phase 2/3 Completed

Leiomyoma